Albert Graf
Venture Partner @ New Enterprise Associates
Menlo Park, United States
Albert Graf is a Series B investor at New Enterprise Associates in Menlo Park focused on Health Care and Medical Device. Albert Jay Graf is based out of Menlo Park, California and is the Venture Partner of New Enterprise Associates. Albert previously worked at Guidant as a Group Chairman. Albert Jay Graf attended the Indiana University Bloomington. He passed away on January 8th, 2024.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries Albert Graf invests in
Stages Albert Graf invests in
Countries Albert Graf invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (45%)
- Medical Device 5 (45%)
- Medical 3 (27%)
- Biotechnology 3 (27%)
- Health Diagnostics 2 (18%)
Stage
- Series B 2 (18%)
- Series C 1 (9%)
- Series E 1 (9%)
- Series F 1 (9%)
- Series G 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left andright carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota. | $50M / Private Equity / Jul 07, 2020 | ||
| CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left andright carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota. | $93M / Series G / Aug 09, 2019 | ||
| Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota. | $12M / Series B / Aug 16, 2016 | ||
| VytronUS, Inc. manufactures and markets cardiac medical devices. VytronUS, Inc. was formerly known as CardionUS, Inc. The company was founded in 2006 and is based in Sunnyvale, California. | $49M / Series C / Jul 29, 2016 | ||
| Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology. | $25M / Series B / Sep 23, 2014 | ||
| Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota. | $27.2M / Series B / Jul 02, 2014 | ||
| Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology. | $14M / Series B / Jan 13, 2014 | ||
| CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left andright carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota. | $29.6M / Series F / Jul 10, 2013 | ||
| Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology. | $27M / Series B / Jan 31, 2013 | ||
| Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy). | $18.3M / Series E / Jun 07, 2010 | ||
| See all 11 investments → | |||
Co-Investors
New Enterprise Associates offers capital and operational support to businesses throughout various development stages, ranging from initial seed rounds to public offerings. Its investment focus includes diverse industries such as software, consumer technology, medical devices, and biopharmaceuticals. The firm works alongside founders to address technical challenges and navigate changing economic environments. Beyond funding, the entity delivers domain expertise and functions as a collaborator for product development and market expansion.
New Enterprise Associates Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Albert Graf
Venture Partner
|
|||
Alex Sharata
Associate
|
|||
Anthony Florence
General Partner
|
|||
Bala Deshpande
Sr. Managing Director, India
|
|||
Hilarie Koplow-McAdams
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Albert Graf invest in?
Albert Graf invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Series C stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Albert Graf?
Public channels for Albert Graf include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Albert Graf last invest?
The most recent investment recorded for Albert Graf closed in Jul 2020. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
